Intraocular encapsulation of oxygenic bacteria
US8883189B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 26, 2012 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Sep 26, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K35/748
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Exemplary embodiments comprise an implantable ophthalmic device comprising at least one shell encapsulating oxygenic bacteria and growth medium and designed to increase the oxygen partial pressure in an oxygen-deprived structure of, or space within, an eye. Exemplary embodiments may be used therapeutically to treat ischemic retinopathies in situ and thereby prevent damage, for example, retinal damage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.